Cambridge Investment Research Advisors’s Innovator Growth-100 Power Buffer ETF - December NDEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$550K Sell
18,325
-1,049
-5% -$30.7K ﹤0.01% 2663
2026
Q1
$522K Sell
19,374
-1,488
-7% -$41.1K ﹤0.01% 2771
2025
Q4
$579K Buy
20,862
+1,980
+10% +$54.4K ﹤0.01% 2579
2025
Q3
$511K Sell
18,882
-1,493
-7% -$39.4K ﹤0.01% 2663
2025
Q2
$526K Sell
20,375
-686
-3% -$16.7K ﹤0.01% 2508
2025
Q1
$496K Hold
21,061
﹤0.01% 2447
2024
Q4
$514K Buy
+21,061
New +$518K ﹤0.01% 2411

Other funds holding NDEC

Cambridge Investment Research Advisors's NDEC Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Innovator Growth-100 Power Buffer ETF - December (NDEC) stake by 5.4% in Q2 2026, selling an estimated $30.7K and leaving 18,325 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #2663.

Cambridge Investment Research Advisors first reported a position in NDEC in Q4 2024 and has held it in 7 quarters since. The position peaked at $579K in Q4 2025. 13 funds tracked by Wall St. Rank hold NDEC as of Q2 2026.

  • Cambridge Investment Research Advisors held 18,325 shares of Innovator Growth-100 Power Buffer ETF - December worth $550K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 1,049 Innovator Growth-100 Power Buffer ETF - December shares in Q2 2026, an estimated $30.7K.
  • Innovator Growth-100 Power Buffer ETF - December made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2663 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator Growth-100 Power Buffer ETF - December in Q4 2024 and has held it in 7 quarters since.
  • Cambridge Investment Research Advisors's Innovator Growth-100 Power Buffer ETF - December position peaked at $579K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Innovator Growth-100 Power Buffer ETF - December as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.